Allogeneic MesenCure

allogeneic mesenchymal stem cell therapy · BonusBio Group Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic MesenCure, covering 2025-08-11 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: A Controlled Study to Evaluate the Efficacy of Allogeneic MesenCure for the Treatment of Patients With ARDS [Phase 3]

See pricing